George Washington University, US
An update on Infl ammation & coronary disease
UZ Gent
Limited Psoriasis in Belgium & Luxemburg
UZ Leuven
Early PsA
George Washington University, US
UZ Gent
UZ Leuven
An update on Inflammation & coronary disease
Limited Psoriasis in Belgium & Luxemburg
Early PsA
L’Atelier Cuisine
Voie de l’Air Pur, 207
4052 Beaufays
Moderator:
Dermato: Dr. Florence Bourlon
Rheumato: Dr. Cédric Péters
Dis moi où?
Rue Emile Marcq 3
1474 Genappe
Moderator:
Dermato: NA
Rheumato: Dr. Steinfield
Faculty Club
Groot Begijnhof 14
3000 Leuven
Moderator:
Dermato: Dr. Tom Hillary
Rheumato: Dr. Alla Ishchenko
Auberge du Pêcheur
Pontstraat 41
9831 Sint-Martens-Latem
Moderator:
Dermato: Dr. Sven Lanssens
Rheumato: Prof. Philippe Carron
*1 https://www.amgen.be/hcp-privacy-statement
*2 I hereby confirm that the above mentioned email address is my personal and I have it at my disposal. Based on your consent, Amgen n.v. will collect and process your information with the sole intended purpose of providing you with the information and/or services requested and for promoting Amgen´s products and professional or scientific activities. Such activities may include your participation in trainings, clinical or market research activities, scientific congresses and meetings or advisory boards, together with digital surveys about our products, services or activities; all of them relevant for your practice. Amgen processes your personal data for the duration of the relationship between you and Amgen, in any event as long as required by legal retention obligations (e.g., tax laws). This information may be used within the Amgen Group of companies in and outside of EU countries and may be transferred to a third party providing services. Amgen is a multi-national company headquartered in the United States. Amgen maintains data centers around the world, including in the European Union and the United States. Amgen may process personal information in global databases that can be accessed by authorized Amgen personnel worldwide. Transfers outside of Europe including to the United States are made in accordance with applicable privacy laws. Transfers of personal information among Amgen and its group entities follow applicable laws and our Binding Corporate Rules (BCRs). For more information on the BCRs, including your ability to file a complaint about any processing of your personal information in violation of the BCRs, please visit http://www.amgen.com/bcr/. Transfers of personal information in countries not deemed adequate is done using appropriate safeguards such as Standard Contractual Clauses. To obtain a copy of these safeguards, please contact your Data Protection Officer at privacy@amgen.com. Regardless of where your personal information is collected or processed, Amgen maintains and shall ensure that third parties processing data under Amgen’s instruction as data processor service providers maintain appropriate administrative, technical and physical safeguards to protect information about you. You may access, cancel and rectify your personal information as well as request your right to data portability contacting Amgen’s Data Protection Officer at privacy@amgen.com. You may also withdraw your consent to receive such promotional messages at any time by following the instructions provided in each electronic message sent to you. You may also lodge a complaint either by contacting Amgen’s Data Protection Officer at privacy@amgen.com, or directly to the Belgian Data Protection Authority, Drukpersstraat 35, 1000 Brussel. More information on how Amgen is processing your personal information and your rights is available in Amgen’s privacy statement.
Organised by
Approval number: BEL-407-26-80017 – V1.0 – creation date 6 May 2026
Post-ESMO Meeting 2025, Reserveer nu je plaats!
Mis de jaarlijkse update van de meest impactvolle ESMO-inzichten niet.
👉 Schrijf je in voor de 3e Nederlandstalige Post-ESMO Meeting op 12 november in Gent, Hasselt of Sint-Katelijne-Waver.
Exclusief voor zorgprofessionals.